164 related articles for article (PubMed ID: 25305319)
1. Polymorphism in the innate immune receptor SIRPα controls CD47 binding and autoimmunity in the nonobese diabetic mouse.
Wong AS; Mortin-Toth S; Sung M; Canty AJ; Gulban O; Greaves DR; Danska JS
J Immunol; 2014 Nov; 193(10):4833-44. PubMed ID: 25305319
[TBL] [Abstract][Full Text] [Related]
2. The Immunoregulatory Role of the Signal Regulatory Protein Family and CD47 Signaling Pathway in Type 1 Diabetes.
Sharp RC; Brown ME; Shapiro MR; Posgai AL; Brusko TM
Front Immunol; 2021; 12():739048. PubMed ID: 34603322
[TBL] [Abstract][Full Text] [Related]
3. Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity.
Kuo TC; Chen A; Harrabi O; Sockolosky JT; Zhang A; Sangalang E; Doyle LV; Kauder SE; Fontaine D; Bollini S; Han B; Fu YX; Sim J; Pons J; Wan HI
J Hematol Oncol; 2020 Nov; 13(1):160. PubMed ID: 33256806
[TBL] [Abstract][Full Text] [Related]
4. KLRG1 expression identifies short-lived Foxp3
Kornete M; Mason E; Istomine R; Piccirillo CA
Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
[TBL] [Abstract][Full Text] [Related]
5. Genes within the Idd5 and Idd9/11 diabetes susceptibility loci affect the pathogenic activity of B cells in nonobese diabetic mice.
Silveira PA; Chapman HD; Stolp J; Johnson E; Cox SL; Hunter K; Wicker LS; Serreze DV
J Immunol; 2006 Nov; 177(10):7033-41. PubMed ID: 17082619
[TBL] [Abstract][Full Text] [Related]
6. Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity.
Ring NG; Herndler-Brandstetter D; Weiskopf K; Shan L; Volkmer JP; George BM; Lietzenmayer M; McKenna KM; Naik TJ; McCarty A; Zheng Y; Ring AM; Flavell RA; Weissman IL
Proc Natl Acad Sci U S A; 2017 Dec; 114(49):E10578-E10585. PubMed ID: 29158380
[TBL] [Abstract][Full Text] [Related]
7. Cancer immunotherapy targeting the CD47/SIRPα axis.
Weiskopf K
Eur J Cancer; 2017 May; 76():100-109. PubMed ID: 28286286
[TBL] [Abstract][Full Text] [Related]
8. Signal-regulatory protein α from the NOD mouse binds human CD47 with an exceptionally high affinity-- implications for engraftment of human cells.
Kwong LS; Brown MH; Barclay AN; Hatherley D
Immunology; 2014 Sep; 143(1):61-7. PubMed ID: 24786312
[TBL] [Abstract][Full Text] [Related]
9. Genetic and functional data identifying Cd101 as a type 1 diabetes (T1D) susceptibility gene in nonobese diabetic (NOD) mice.
Mattner J; Mohammed JP; Fusakio ME; Giessler C; Hackstein CP; Opoka R; Wrage M; Schey R; Clark J; Fraser HI; Rainbow DB; Wicker LS
PLoS Genet; 2019 Jun; 15(6):e1008178. PubMed ID: 31199784
[TBL] [Abstract][Full Text] [Related]
10. Two genetic loci regulate T cell-dependent islet inflammation and drive autoimmune diabetes pathogenesis.
Fox CJ; Paterson AD; Mortin-Toth SM; Danska JS
Am J Hum Genet; 2000 Jul; 67(1):67-81. PubMed ID: 10848492
[TBL] [Abstract][Full Text] [Related]
11. CD47-SIRPα Interactions Regulate Macrophage Uptake of Plasmodium falciparum-Infected Erythrocytes and Clearance of Malaria In Vivo.
Ayi K; Lu Z; Serghides L; Ho JM; Finney C; Wang JCY; Liles WC; Kain KC
Infect Immun; 2016 Jul; 84(7):2002-2011. PubMed ID: 27091932
[TBL] [Abstract][Full Text] [Related]
12. Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment.
Yamauchi T; Takenaka K; Urata S; Shima T; Kikushige Y; Tokuyama T; Iwamoto C; Nishihara M; Iwasaki H; Miyamoto T; Honma N; Nakao M; Matozaki T; Akashi K
Blood; 2013 Feb; 121(8):1316-25. PubMed ID: 23293079
[TBL] [Abstract][Full Text] [Related]
13. Treg Cells Protect Dopaminergic Neurons against MPP+ Neurotoxicity via CD47-SIRPA Interaction.
Huang Y; Liu Z; Cao BB; Qiu YH; Peng YP
Cell Physiol Biochem; 2017; 41(3):1240-1254. PubMed ID: 28268219
[TBL] [Abstract][Full Text] [Related]
14. The CD47-SIRPα Immune Checkpoint.
Logtenberg MEW; Scheeren FA; Schumacher TN
Immunity; 2020 May; 52(5):742-752. PubMed ID: 32433947
[TBL] [Abstract][Full Text] [Related]
15. Novel structural determinants on SIRP alpha that mediate binding to CD47.
Lee WY; Weber DA; Laur O; Severson EA; McCall I; Jen RP; Chin AC; Wu T; Gernert KM; Parkos CA
J Immunol; 2007 Dec; 179(11):7741-50. PubMed ID: 18025220
[TBL] [Abstract][Full Text] [Related]
16. The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer.
Matlung HL; Szilagyi K; Barclay NA; van den Berg TK
Immunol Rev; 2017 Mar; 276(1):145-164. PubMed ID: 28258703
[TBL] [Abstract][Full Text] [Related]
17. Sex-specific effect of insulin-dependent diabetes 4 on regulation of diabetes pathogenesis in the nonobese diabetic mouse.
Ivakine EA; Fox CJ; Paterson AD; Mortin-Toth SM; Canty A; Walton DS; Aleksa K; Ito S; Danska JS
J Immunol; 2005 Jun; 174(11):7129-40. PubMed ID: 15905556
[TBL] [Abstract][Full Text] [Related]
18. Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPα.
Sim J; Sockolosky JT; Sangalang E; Izquierdo S; Pedersen D; Harriman W; Wibowo AS; Carter J; Madan A; Doyle L; Harrabi O; Kauder SE; Chen A; Kuo TC; Wan H; Pons J
MAbs; 2019; 11(6):1036-1052. PubMed ID: 31257988
[TBL] [Abstract][Full Text] [Related]
19. A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncology.
Burgess TL; Amason JD; Rubin JS; Duveau DY; Lamy L; Roberts DD; Farrell CL; Inglese J; Thomas CJ; Miller TW
PLoS One; 2020; 15(4):e0226661. PubMed ID: 32240171
[TBL] [Abstract][Full Text] [Related]
20. The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment.
Iwamoto C; Takenaka K; Urata S; Yamauchi T; Shima T; Kuriyama T; Daitoku S; Saito Y; Miyamoto T; Iwasaki H; Kitabayashi I; Itoh K; Kishimoto J; Kohda D; Matozaki T; Akashi K
Exp Hematol; 2014 Mar; 42(3):163-171.e1. PubMed ID: 24269920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
